Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))

F. I. Mulder, N. van Es, N. Kraaijpoel, M. Di Nisio, M. Carrier, A. Duggal, M. Gaddh, D. Garcia, M. A. Grosso, A. K. Kakkar, M. F. Mercuri, S. Middeldorp, G. Royle, A. Segers, S. Shivakumar, P. Verhamme, T. Wang, J. I. Weitz, G. Zhang, H. R. BüllerG. Raskob

科研成果: 期刊稿件评论/辩论同行评审

2 引用 (Scopus)
源语言英语
页(从-至)156-159
页数4
期刊Thrombosis Research
191
DOI
出版状态已出版 - 7月 2020
已对外发布

!!!ASJC Scopus Subject Areas

  • 血液学

指纹

探究 'Corrigendum to “Edoxaban for treatment of venous thromboembolism in patient groups with different types of cancer: Results from the Hokusai VTE Cancer study” [Thromb. Res. vol. 185, January 2020, pages 13–19] (Thrombosis Research (2020) 185 (13–19), (S0049384819304931), (10.1016/j.thromres.2019.11.007))' 的科研主题。它们共同构成独一无二的指纹。

引用此